Researchers from VIB (Flanders Institute for Biotechnology) and Ghent University have shown that a defective gene can contribute to the onset of rheumatoid arthritis, an often-crippling inflammation of the joints that afflicts ...
Aug 16, 2011
0
0
In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide ...
Jul 18, 2011
0
0
Individuals with systemic inflammatory conditions, such as rheumatoid arthritis (RA) and psoriasis, experience a 1.5 to 2-fold increased rate of cardiovascular disease. Previous research suggests that inflammation and insulin ...
Jun 21, 2011
0
0
A new government report finds that federal regulators need to do more to help in the battle to keep kids and teens off tobacco.
Sep 21, 2023
0
5
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease—both the result ...
Jun 27, 2023
0
15
Arthritis strikes millions of Americans, leaving them with aching, inflamed joints that make it hard to move around without pain.
Apr 17, 2023
0
17
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
In a study published in Arthritis & Rheumatology of Swedish women were pregnant, those with psoriatic arthritis (PsA) were more likely to experience preterm birth and require cesarean delivery.
Oct 20, 2021
0
2
Since doctors began treating cancer patients with immunotherapy drugs called checkpoint inhibitors nearly a decade ago, they have observed that a subset of these patients experience a side effect that clinically looks like ...
Nov 9, 2020
0
2
New research presented at ACR Convergence, the American College Rheumatology's annual meeting, showed that patients with rheumatic diseases whose infliximab treatment was individually assessed and adjusted with a new strategy ...
Nov 6, 2020
0
1
